From Diligence to Post-Closing: What’s Shifting in 2026 Health Care Transactions

Joseph Kadlec, Emma Trivax
Troutman Pepper Locke
Contact
LinkedIn
Facebook
X
Send
Embed
On the heels of the 44th Annual J.P. Morgan Health Care Conference, Troutman Pepper Locke attorneys Joe Kadlec and Emma Trivax discuss how AI, shifting regulatory scrutiny, and evolving investor oversight are reshaping health care transactions and preview what dealmakers should expect in 2026.
Embed
Copy
Send Report

Other MultiMedia by Troutman Pepper Locke

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Troutman Pepper Locke

Written by:

Troutman Pepper Locke
Troutman Pepper Locke
Contact
more
less

What do you want from legal thought leadership?

Please take our short survey – your perspective helps to shape how firms create relevant, useful content that addresses your needs:

Troutman Pepper Locke on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide